BDSI: Collegium Completes the Acquisition of BDSI

STOUGHTON, Mass., March 22, 2022 (GLOBE NEWSWIRE) - Collegium Pharmaceutical, Inc. (Nasdaq: COLL) ("Collegium") today announced that it has completed the acquisition of BioDelivery Sciences International Inc. (Nasdaq: BDSI) ("BDSI"). "This acquisition is a major step forward in our mission to build a leading, diversified specialty pharmaceutical company committed to improving the lives of people [...]The post Collegium Completes the Acquisition of BDSI first appeared on Life Care News.